Position in LGVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,973
-$7,179 QoQ
Shares Held
21,300
0.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 39 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $3,273,847 across 13 Biotechnology names. LGVN ranks #13 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADAG |
Adagene Inc.
|
200,000 | $840,000 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
895 | $444,573 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
4,715 | $409,969 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
502 | $313,017 | |
| 5 | CAI |
Caris Life Sciences, Inc.
|
17,159 | $305,773 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
815 | $232,250 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
9,399 | $226,327 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
14,525 | $149,607 |
All Filings in LGVN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,973 | 21,300 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,152 | 21,300 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $10,777 | 21,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,000 | 12,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||